Biocon shares were trading 3.3% higher in today's session at Rs 391 at the time of publication of this story. The stock opened at Rs 384 and touched an intraday high at Rs 394.50.
Senores Pharmaceuticals Ltd's initial public offering (IPO), worth ₹582 crore, witnessed an extraordinary response from investors, achieving an astounding 93.69-times subscription on its final bidd
Senores Pharmaceuticals Ltd, an Ahmedabad-based pharmaceutical firm, announced that it raised nearly Rs 261 crore from anchor investors before the public subscription of its initial public offering
Granules India announced on Tuesday that its US subsidiary, Granules Pharmaceuticals, Inc (GPI), has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug